Stem cell trial for spinal cord injuries cleared by FDA – San Francisco Business Times (blog)
|
Stem cell trial for spinal cord injuries cleared by FDA
San Francisco Business Times (blog) Asterias Biotherapeutics Inc. of Menlo Park received Food and Drug Administration clearance Wednesday to go forward with a 13-person safety study of so-called oligodendrocyte progenitor cells, or OPCs. Those cells, derived from embryonic stem cells … Asterias cleared for stem cell trial in spinal cord injury Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a … |
